What was the overall market valuation of the US chromatography columns market in 2024?

The overall market valuation was $3500.0 Million in 2024. Read More

What is the projected market valuation for the US chromatography columns market by 2035?

The projected market valuation for 2035 is $6500.0 Million. Read More

What is the expected CAGR for the US chromatography columns market during the forecast period 2025 - 2035?

The expected CAGR for the market during the forecast period 2025 - 2035 is 5.79%. Read More

Which company is a key player in the US chromatography columns market?

Agilent Technologies is one of the key players in the US chromatography columns market. Read More

What are the revenue ranges for Normal Phase Chromatography Columns in the US market?

The revenue range for Normal Phase Chromatography Columns is $700.0 Million to $1300.0 Million. Read More

What is the revenue range for Automated Chromatography Columns in the US market?

The revenue range for Automated Chromatography Columns is $1400.0 Million to $2600.0 Million. Read More

Which chromatography type has the highest revenue range in the US market?

Gas Chromatography has the highest revenue range, estimated between $1200.0 Million and $2200.0 Million. Read More

What is the revenue range for Protein Purification applications in the US chromatography columns market?

The revenue range for Protein Purification applications is $900.0 Million to $1700.0 Million. Read More

Which end user segment is projected to generate the highest revenue in the US chromatography columns market?

Pharmaceutical Biotechnology Companies are projected to generate the highest revenue, ranging from $1400.0 Million to $2600.0 Million. Read More

What is the revenue range for Affinity Chromatography in the US market?

The revenue range for Affinity Chromatography is $800.0 Million to $1500.0 Million. Read More

US Chromatography Columns Market

ID: MRFR/HC/17786-HCR

100 Pages

Rahul Gotadki

Last Updated: April 06, 2026

US Chromatography Columns Market Research Report By Column Type (Normal Phase Chromatography Columns, Pre-Packed Chromatography Columns, Automated Chromatography Columns), By Chromatography Type (Ion Exchange Chromatography, Affinity Chromatography, Gas chromatography, Gel Filtration Chromatography, Others), By Application (Anion and Cation Exchange, Sample Preparation, Resin Screening, Protein Purification, Desalting) and By End User (Research Institutes, Pharmaceutical Biotechnology Companies, Food & Beverage Manufacturers, Others) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Pharmaceutical, BY Column Type (USD Million)
  1. 4.1.1 Normal Phase Chromatography Columns
  2. 4.1.2 Prepacked Chromatography Columns
  3. 4.1.3 Automated Chromatography Columns
2. 4.2 Pharmaceutical, BY Chromatography Type (USD Million)
  1. 4.2.1 Ion Exchange Chromatography
  2. 4.2.2 Affinity Chromatography
  3. 4.2.3 Gas Chromatography
  4. 4.2.4 Size Exclusion Chromatography
3. 4.3 Pharmaceutical, BY Application (USD Million)
  1. 4.3.1 Anion & Cation Exchange
  2. 4.3.2 Sample Preparation
  3. 4.3.3 Resin Screening
  4. 4.3.4 Protein Purification
  5. 4.3.5 Desalting
4. 4.4 Pharmaceutical, BY End User (USD Million)
  1. 4.4.1 Research Institutes
  2. 4.4.2 Pharmaceutical Biotechnology Companies
  3. 4.4.3 Food & Beverage Manufacturers
  4. 4.4.4 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Pharmaceutical
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Agilent Technologies (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Thermo Fisher Scientific (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Waters Corporation (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Merck KGaA (DE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 PerkinElmer (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Shimadzu Corporation (JP)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Sartorius AG (DE)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Bio-Rad Laboratories (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Jasco, Inc. (JP)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY COLUMN TYPE
3. 6.3 US MARKET ANALYSIS BY CHROMATOGRAPHY TYPE
4. 6.4 US MARKET ANALYSIS BY APPLICATION
5. 6.5 US MARKET ANALYSIS BY END USER
6. 6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF PHARMACEUTICAL
9. 6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
10. 6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
11. 6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
12. 6.12 PHARMACEUTICAL, BY COLUMN TYPE, 2024 (% SHARE)
13. 6.13 PHARMACEUTICAL, BY COLUMN TYPE, 2024 TO 2035 (USD Million)
14. 6.14 PHARMACEUTICAL, BY CHROMATOGRAPHY TYPE, 2024 (% SHARE)
15. 6.15 PHARMACEUTICAL, BY CHROMATOGRAPHY TYPE, 2024 TO 2035 (USD Million)
16. 6.16 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
17. 6.17 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Million)
18. 6.18 PHARMACEUTICAL, BY END USER, 2024 (% SHARE)
19. 6.19 PHARMACEUTICAL, BY END USER, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY COLUMN TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY CHROMATOGRAPHY TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY APPLICATION, 2025-2035 (USD Million)
  4. 7.2.4 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Pharmaceutical Market Segmentation

Pharmaceutical By Column Type (USD Million, 2025-2035)

Normal Phase Chromatography Columns
Prepacked Chromatography Columns
Automated Chromatography Columns

Pharmaceutical By Chromatography Type (USD Million, 2025-2035)

Ion Exchange Chromatography
Affinity Chromatography
Gas Chromatography
Size Exclusion Chromatography

Pharmaceutical By Application (USD Million, 2025-2035)

Anion & Cation Exchange
Sample Preparation
Resin Screening
Protein Purification
Desalting

Pharmaceutical By End User (USD Million, 2025-2035)

Research Institutes
Pharmaceutical Biotechnology Companies
Food & Beverage Manufacturers
Others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”